Skip to main content
. 2020 Feb 25;10:198. doi: 10.3389/fonc.2020.00198

Figure 1.

Figure 1

A 51-year-old female with pancreatic ductal adenocarcinoma in body and tail with hepatic metastases. (A–J) Whole body PET image with maximum intensity projection (MIP) (A) and axial abdominal PET image (B) showed FDG metabolism increased lesion in pancreatic body and tail, with SUVmax 7.52, SUVpeak 6.39, and MTV 17.43 cm3. Diffusion weighted imaging (DWI, b = 800) (C) and apparent diffusion coefficient (ADC) map (D) showed a diffusion restricted lesion in pancreatic body and tail. (E) Fused image of PET and ADC showed a diffusion restricted lesion with hyper FDG metabolism. (F) Contrast enhanced (CE) T1 weighted image (T1WI) with fat suppression (fs) on late arterial phase showed hypo-vascular lesion and dilated main pancreatic duct, and the maximum diameter of the lesion was 4.7 cm. (G,H) Metastasis in the right lobe of the liver (arrow) confirmed by surgery operation (2 days after the initial PET/MR examination) and histo-pathological examination, and the lesion showed slightly hyper-intensity on T2 weighted image with fat saturation (G), no FDG avid lesion on PET image (H). (I–J) Follow up PET/MR 112 days after operation showed the operated region with hyper-intensity in T2 weighted image with fat saturation (J) and without abnormal FDG uptake on PET image (I).